Cargando…
LRBA Deficiency Can Lead to Lethal Colitis That Is Diminished by SHIP1 Agonism
Humans homozygous for inactivating LRBA (lipopolysaccharide (LPS)-responsive beige-like anchor) mutations or with compound heterozygous mutations exhibit a spectrum of immune-related pathologies including inflammatory bowel disease (IBD). The cause of this pathology remains undefined. Here we show t...
Autores principales: | Sudan, Raki, Fernandes, Sandra, Srivastava, Neetu, Pedicone, Chiara, Meyer, Shea T., Chisholm, John D., Engelman, Robert W., Kerr, William G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9116273/ https://www.ncbi.nlm.nih.gov/pubmed/35603158 http://dx.doi.org/10.3389/fimmu.2022.830961 |
Ejemplares similares
-
LRBA is Essential for Allogeneic Responses in Bone Marrow Transplantation
por: Park, Mi Young, et al.
Publicado: (2016) -
Obesity control by SHIP inhibition requires pan-paralog inhibition and an intact eosinophil compartment
por: Fernandes, Sandra, et al.
Publicado: (2023) -
Targeting SHIP1 and SHIP2 in Cancer
por: Pedicone, Chiara, et al.
Publicado: (2021) -
SHIP1 Deficiency in Inflammatory Bowel Disease Is Associated With Severe Crohn’s Disease and Peripheral T Cell Reduction
por: Fernandes, Sandra, et al.
Publicado: (2018) -
Role of Inositol Poly-Phosphatases and Their Targets in T Cell Biology
por: Srivastava, Neetu, et al.
Publicado: (2013)